Daily non-political popular news in brief.
New target for anti-flu drug development
08-15-2007 · EurekAlert!Scientists at Cure Lab, Inc., a biotechnology company based in Canton, Mass., in collaboration with researchers at Boston University and Harvard Medical School have discovered a potential new target for the development of anti-flu drugs, including those that may be effective against potentially pandemic influenza strains like H5N1. The findings have been published in the Aug. 15, 2007, issue of the journal Cell Cycle. A figure from their paper was selected for the journal cover.
Read more »
Keywords: target, anti-flu, drug, development, anti, flu
« Previous | Next »
Similar news on "New target for anti-flu drug development":
- Protein's tail may be flu virus's achilles heel
12-06-2006 · EurekAlert!
New research from Rice University and the University of Texas at Austin (UT) has revealed a potential new target that drug makers can use to attack several strains of influenza, including those that cause bird flu. The research, published online December 6 by Nature, offers evidence of a potential drug target in a flu protein that plays a vital role in all strains of influenza A, including Hong Kong flu, Spanish flu and bird flu.
Similar news · Read more »
- Scientists identify fundamental brain defect, probable drug target in fragile X syndrome
09-17-2007 · EurekAlert!
Scientists have discovered how the gene mutation responsible for fragile X syndrome -- the most common inherited form of mental retardation -- alters the way brain cells communicate. In neurons cultured from laboratory rats, the scientists also were able to reverse the effects of the mutation using a drug targeted to the specific site in an upstream pathway of the defect. The finding could lead to the development of human therapies for this previously untreatable condition.
Similar news · Read more »
- Study reveals a key to blood vessel growth and possible drug target
10-14-2007 · EurekAlert!
Researchers have identified a molecular pathway that plays a critical role in the growth of blood vessels. The finding not only offers an important insight into the development of the vascular system during embryonic development but suggests a potential target for inhibiting the blood vessels that fuel cancers, diabetic eye complications and atherosclerosis, the researchers say.
Similar news · Read more »
- Liver fibrosis will be treated by a potential target
10-16-2007 · EurekAlert!
The hepatitis is either self recovery or its development into liver fibrosis or, further, liver cirrhosis. Since no ideal drug is available, liver fibrosis is currently considered to be a major worldwide health problem. A research conducted by by Dr. ZH Liu from Jilin University found that ARIP2 participates in the negative feedback regulation of signal transduction in the late stage by affecting the expression of ActRIIA, which further suggests that ARIP2 might be a potential target for treatment of liver fibrosis induced by activin.
Similar news · Read more »
- Researchers identify protein pathway involved in Parkinson disease development
06-18-2007 · EurekAlert!
Scientists have found a novel signaling pathway in cells that is altered by genetic mutations recently identified in Parkinson disease development. These new findings show how the mutations affect cellular function and could provide a target for drug therapies to treat the disease.
Similar news · Read more »
- Mutation improves memory, may lead to memory-enhancing pill
04-05-2007 · EurekAlert!
A mind-altering mutation in mice results in an enhanced long-term memory, researchers report in the April 6, 2007, issue of the journal Cell, published by Cell Press. These findings point to a potential target for the development of a drug to treat memory loss, according to the researchers.
Similar news · Read more »
- Jefferson scientists find protein may be key in developing deadly form of pancreatic cancer
10-11-2007 · EurekAlert!
A tumor-blocking protein previously implicated in prostate and breast cancer development may also be behind the most aggressive type of pancreatic cancer. Researchers have discovered that the protein pp32 -- which normally applies the brakes on a cancer-causing gene -- is missing in an aggressive form of pancreatic cancer. Though the work is preliminary, the scientists say, the absent protein could eventually become a marker for the disease and a potential drug target.
Similar news · Read more »
- Key Function Of Nervous System Enzyme Found; Impact On Drug Development Against Alzheimer's
09-29-2006 · ScienceDaily
Ever since scientists first elucidated the molecular mechanisms underlying the pathology and loss of nerve cells in Alzheimer's disease, drug companies have been working to develop drugs which will inhibit the outbreak of this severe form of dementia. Now researchers in Munich and Berlin (Germany) have discovered that an enyzme which has a central causal role in Alzheimer's disease happens also to have a key function in the normal development of the nervous system. This enzyme, beta-secretase or BACE1, ensures that nerve fibers (axons) are adequately isolated with sheaths of myelin, enabling rapid conduction of electrical impulses, as well as preventing short-circuits, akin to plastic insulation on electrical wires.
Similar news · Read more »
- Ireland Cancer Center researchers advance lung cancer treatment
04-23-2007 · EurekAlert!
Researchers at the Ireland Cancer Center of University Hospitals Case Medical Center have developed methods for treating lung cancer cells that have become resistant to new anti-cancer agents, such as Tarceva (erlotinib). Using a new second-generation of Tarceva-like medications, researchers can overcome the drug resistance, and such drugs are now in development including in clinical trials at the Ireland Cancer Center.
Similar news · Read more »
- Study: Fountain of youth for your heart?
11-02-2007 · EurekAlert!
University of Alberta professor Jason Dyck's findings suggest that the protein responsible for transporting fat into the contractile cells of the heart may be a candidate for drug inhibition and that this drug could protect the heart from aging. This research holds great promise for human beings. Dyck hopes it will lead to the development of medications that inhibit the uptake of fatty acids into the heart and prevent and/or reverse the effects of aging on the heart muscle.
Similar news · Read more »
